Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rucaparib maintenance therapy in locally advanced cervical cancer
2018-003756-20Phase 2Terminated
- Sponsor
- Nordic Society of Gynaecological Oncology Clinical Trial Unit
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cervical Cancer (CC) comparing Rucaparib maintenance with Placebo maintenance (2 arms). Primary endpoint: Progression-free survival (overall population). Started Aug 2019; status: terminated.
02
Drugs
rucaparib
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2018-003756-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003756-20.